Your browser doesn't support javascript.
loading
Safety of Direct Drug Provocation for the Evaluation of Penicillin Allergy in Low-Risk Adults.
Brillant-Marquis, Frédéric; Proulx, Émilie; Ratnarajah, Kayadri; Lavoie, Aubert; Gauthier, Amélie; Gagnon, Rémi; Boursiquot, Jean-Nicolas; Verreault, Nina; Marois, Louis; Bédard, Marc-Antoine; Boivin, Martine; Bédard, Pierre-Michel; Ouakki, Manale; De Serres, Gaston; Drolet, Jean-Philippe.
Affiliation
  • Brillant-Marquis F; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Proulx É; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Ratnarajah K; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Lavoie A; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Gauthier A; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Gagnon R; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Boursiquot JN; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Verreault N; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Marois L; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Bédard MA; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Boivin M; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Bédard PM; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada.
  • Ouakki M; Institut National de Santé Publique du Québec, Québec City, Québec, Canada.
  • De Serres G; Institut National de Santé Publique du Québec, Québec City, Québec, Canada.
  • Drolet JP; Division of Allergy and Clinical Immunology, Department of Medicine, Centre Hospitalier Universitaire de Québec-Université Laval, Québec City, Québec, Canada. Electronic address: jean-philippe.drolet.med@ssss.gouv.qc.ca.
J Allergy Clin Immunol Pract ; 12(2): 451-457.e2, 2024 02.
Article in En | MEDLINE | ID: mdl-38572700
ABSTRACT

BACKGROUND:

About 10% of patients have a penicillin allergy label, but less than 5% of them are actually allergic. Unnecessary penicillin avoidance is associated with serious medical consequences. Given the growing number of these labels, it is imperative that our diagnostic strategy for penicillin allergy be as efficient as possible. The validity of traditionally used skin tests (STs) has been questioned, whereas drug provocation testing (DPT), the criterion standard, without previous ST appears very safe in most cases.

OBJECTIVE:

To evaluate the safety of direct DPT without consideration for ST results and the validity of ST in the diagnosis of penicillin allergy.

METHODS:

In this prospective cohort study without a control group, we recruited patients consulting an allergist for penicillin allergy. Patients underwent ST followed by DPT regardless of ST results. Patients with anaphylaxis to penicillin within the past 5 years or a severe delayed reaction were excluded, as were those with significant cardiorespiratory comorbidity.

RESULTS:

None of the 1002 recruited patients had a serious reaction to DPT. Ten (1.0%) had a mild immediate reaction, of whom only 1 (0.1%) was considered likely IgE-mediated. The positive and negative predictive values of ST for an immediate reaction were 3.6% and 99.1%, respectively.

CONCLUSIONS:

In a low-risk adult population reporting penicillin allergy, ST has very poor positive predictive value. Direct DPT without ST is safe and appears to be an ideal diagnostic strategy to remove penicillin allergy labels that could be implemented in first-line practice.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Hypersensitivity / Anaphylaxis Limits: Adult / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Hypersensitivity / Anaphylaxis Limits: Adult / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2024 Document type: Article Affiliation country: Canada Country of publication: United States